<< Вернуться к списку статей журнала

Том 1 №2,3 1999 год - Нефрология и диализ

Качество жизни пациентов с хронической почечной недостаточностью, корригируемой заместительной терапией Обзор литературы

Земченков А.Ю. Кондуров С.В. Гаврик С.Л. Райхельсон К.Л. Эдельштейн В.А.

Аннотация: Введение Совершенствование методов заместительной терапии (ЗТ) хронической почечной недостаточности (ХПН) и, в частности, применение современных диализных технологий, введение в клиническую практику новых методов, обеспечивающих адекватное и щадящее лечение, как и введение в клиническую практику эритропоэтина обеспечило значительное снижение интеркуррентной заболеваемости и смертности больных ХПН. Но в то же время это выдвинуло на первый план проблему их качества жизни (КЖ) [5]. Задачей современной нефрологии становится приближение параметров КЖ пациентов с ХПН, получающих ЗТ, к таковой в популяции здоровых лиц. В последние годы термин «качество жизни» широко используется в мире. Рост интереса к этой проблеме является показателем стремления к развитию целостного взгляда на человека. Являясь первоначально социологическим понятием, термин КЖ в настоящее время нашел употребление в медицине. На современном этапе развития медицина приходит к той точке зрения, что хорошее состояние здоровья является отражением не только уровня медицинской помощи, но и удовлетворения потребностей индивидуума, его адаптации в физической, психологической и социальной сферах.

Для цитирования: Земченков А.Ю., Кондуров С.В., Гаврик С.Л., Райхельсон К.Л., Эдельштейн В.А. Качество жизни пациентов с хронической почечной недостаточностью, корригируемой заместительной терапией Обзор литературы. Нефрология и диализ. 1999. 1(2,3):118-127. doi:

Весь текст

Ключевые слова: качество жизни, хроническая почечная недостаточность, перитонеальный диализ, гемодиализ

Список литературы:

1. Коц Я.И., Либиц Р.А. Качество жизни у больных с сердечно-сосудистыми заболеваниями. Кардиология. 1993; 5: 66-72.
2. Петрова Н.Н., Васильева И.А. Психическое состояние больных, находящихся на лечении диализом в процессе терапии эритропоэтином. Эритропоэтин в лечении хронической почечной недостаточности. под ред. С.И. Рябова. 1995; 173-185.
3. Петрова Н.Н., Васильева И.А., Гаврик С.Л. Качество жизни больных при лечении перманентным гемодиализом и перитонеальным диализом. Нефрология. 1999; 3; 1: 88-92
4. Рябов С.И., Петрова Н.Н., Васильева И.А. Качество жизни больных, находящихся на лечении гемодиализом. Клиническая медицина. 1996; 8: 29-31.
5. Ahlman J. Ouality of life of the dialysis patient in Replacment of renal function by dialysis. eds. C.Jacobs, C.M. Kjelllstrand, K.M. Koch. - Kluwer Academic Publishers - Dordrecht/Boston/London. 1996; 1466-1479.
6. Auer J., Gokal R., Stout J., Hillier V., Kincey J., Simon R., Oliver D. The Oxford-Manchester Study of dialysis patients. Scand. J. Urol. Nephrol. 1991; 24; Suppl. 131; 31.
7. Auer J, Oliver D, Winearls C. The quality of life of dialysis patients treated with recombinant human erythropoetin. Scand. J. Urol. Nephrol. 1990; 131; Suppl.1; 61.
8. Auer J., Simon G., Stevens J. et al. Quality of life improvements in CAPD-patients treated with subcutaneosly administered erythropoetin for anaemia. Perit. Dial. Int. 1992; 12: 40.
9. Bernger M., Bobbitt R., Kressel S. et al. The Sickness Impact Profil: conceptual formulation and methodology for development of a health status measure. Inf. J. Health Serv. 1978; 6: 393.
10. Beusterien K.M., Nissenson A.R., Port F.K. et al. The effects of recombinant human erythropoetin on functional health and well-being in chronic dialysis patients. J. Am. Soc. Nephrol. 1996; 7; 5: 763-773.
11. Bommer J., Kugel M., Schwobel B. et al. Improved sexual function during recombinant human erythropoetin therapy. Nephrol. Dial. Transplant. 1990; 5; 204.
12. Borgel F., Benhamou P., Zmirou D. et al. Assessment of handicap in chronic dialysis diabetic patients. Scand. J. Rehab. Med. 1992; 24; 203.
13. Borgel F., Pasqvier A., Benhamou P., Halimi S. Evaluation du handicap chez ae patient diabetique. Ann. Readapt. Med. Phys. - 1990; 33; 81.
14. Buckingham J.K., Birdsall J., Douglas J.G. Comparing three versions of the time tradeoff: time for a change? Med. Decis. Making. 1996; 16; 4: 335-47.
15. Campell A., Converse P., Rodgers W. The Quality of American Life. - New York, Russel Sage Foundation. 1976.
16. Cantril H. The patterns of human Concerns. - New Brunswick. Rutgers University Press. 1965.
17. Chowance G., Binyc Y. End stage renal disease and the marital dyad: and empirical investigation. Soc. Sci. Med. 1989; 28: 971.
18. Comty N., Leonard A., Shapiro F. Psychosocial problems in dialyzed diabetic patients. Kidney Int. 1974; 6; Suppl.1. 144.
19. Delano B. Improvements inquality of life following treatment with r-Hu Epo in anaamic hemodialysis patients. Am. J Kidney Dis. - 1989; 14; Suppl. 2. 14.
20. DeOreo P.B. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis, 1997; 30: 2, 204-12.
21. Devins G. Illness intrusiveness and quality of life in end-stage renal disease: comparison and stability across treatment modalities. Health Psychology. 1990; 9; 117.
22. Devins G.M., Binik Y.M., Mandin H. et al. The Kidney Disease Questionnaire: a test for measuring patient knowledge about end-stage renal disease. J. Clin. Epidemiol. 1990; 43; 3: 297-307.
23. NKF-DOQI Clinical Practice Guidlines for Peritoneal Dialysis Adequacy. New York, National Kidney Foundation, 1997; 208 pp.
24. Eschbach J., Egrie J., Downing M. et al. Correction of the anaamia of end-stage renal disease with recombinant human erytropoetin, results of phase I and II clinical trial. N. Eng. J. Med. 1987; 316; 73.
25. Evans R. Recombinant human erythropoetin and the quality of life of end-stage renal disease patients: a comparative analysis. Am. J. Kidney Dis. 1991; 18; Suppl.1. 62.
26. Eveans R.W., Manninen D.L., Garrisson L.R. et al. The quality of life of patients with end stage renal disease. N.Engl.J.Med. 1985; 312; 9: 553-559.
27. Ferrans C., Powers M. Quality of life index: development and psychometric properties. Adv. in Nursing Sci. 1985; 8; 15.
28. Ferrans C., Powers M., Kasch C. Satisfaction with health care of hemodialysis patients. Research in Nursing and Health. 1987; 10; 367.
29. Flynn С. Why blind diabetics with renal failure should be offered treatment. Br. Med. J. 1983; 287; 1177.
30. Fox E., Peace K., Neale T. et al. Quality of life for patients with end-stage renal failure. Renal Failure 1991; 13; 31.
31. Freeman С., Calsyn D., Sherrard D., Paige A. Psychological assessment of renal dialysis patients using standard psychomatric techniques. J. Consulting and Clinical Psychology. 1980; 48; 537.
32. Friedlender R., Viederbrmann M. Children of dialysis patients. Am. J. Psyhiatry. 1982; 139; 100.
33. Gotch F., Sargent J. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int. 1985; 28; 526.
34. Gotch F., Yarian S., Keen M. A kinetic survey of US hemodialysis prescriptions. Am. J. Kidney Dis. 1990; 15; 511.
35. Grimm G., Stockenhuber F., Schneweiss B. et al. Improvement of brain function in hemodialysis patients treated with erytropoetin. Kidney. Int. 1990; 38; 480.
36. Hays R.D., Kallich J.D., Mapes D.L. et al. Development of the kidney disease quality of life (KDQOL) instrument. Qual. Life. Res. 1994; 3; 5: 329-38.
37. Hoothay F., De Stefano A., Leary E., Foley-Hartel T. Life satisfaction and coping of diabetic haemodialysis patients. - ANNA J. 1990; 17; 361.
38. Hunt S., Mc Kenna S., McEven J. The Nottingham Health profile: subjective status and medical consultations. Soc. Sci. Med. 1981; 15; 221.
39. Julius M., Hawthorne V., Carpentier-Alting P. et al. Independence in activities of daily living for end-stage renal disease patients: biomedical and demographic correlates. Am. J. Kidney. Dis. 1989; 13; 61.
40. Julius M., Kneisley J., Carpentier-Alting P. et al. A comparison of employment rates of patients treated with continuous ambulatory peritoneal dialysis vs in center hemodialysis. Arch. Intern. Med. 1989; 149; 839.
41. Kaplan De Nour A. Personlichhheitsfactorer und adaptacion. in Psyhonephrologie. eds. Balch F.B. et al. Berlin. Heidelberg. 1985; 303.
42. Kaplan De Nour A. Stresses and reactions of professional hemodialysis staff. Dial. Transplant. 1984; 13; 137.
43. Karnofsky D., Bucherval J. in the Clinical evolution of chemotherapeutic agents in cancer. eds. Macleod C.M. New York. Colombia University Press. 1949.
44. Koch V., Muthny F. Quality of life in patients with end-stage renal disease in relation to the method of treatment. Psychother Psychosom 1990; 54; 161.
45. Kutner N., Brogan D. Assisted survival aging and rehabilitation needs: comparison of older dialysis patients and age-matched peers. Arch. Phys. Med. Rehabil. 1992; 73; 309.
46. Kutner N., Brogan D., Kutner M. End-stage renal disease treatment modality and patients’ quality of life. Longitudinal assessment. Am. J. Nephrol. 1986; 6; 396.
47. Larsen D., Rootman I. Physician role performance and patient satisfaction. Soc. Sci. Med. 1976; 10; 29.
48. Laupacis A., Canadian Erytropoetin Study Group. Association between recombinant human erytropoetin and quality of life and exercise capacity of patients receiving hemodialysis. Br. Med. J. 1990; 300; 573.
49. Laupacis A., Wong С., Churchill D. and the Canadian erythropoetin study group. The use of generic and specific Quality-of-life measures in hemodialysis patients treated with erytropoetin. Controlled Clinical Trials. 12 (Suppl ). 1991; 168.
50. Levy N. Pcihological reaction to machine dependency. Psychiatry clinics of North America. 1981; 13; 246.
51. Levy N. Sexual adjustment to maintenance hemodialysis and renal transplantation. National survey by questionnaire. Preliminary report. Trans. Am. Soc. Artif. Intern. Organs. 1973; 19; 138.
52. Lindsay R., Oreopoulus D., Burton H. et al. Adaptation to home dialysis: a comparison of continuous ambulatory peritoneal dialysis and hemodialysis in Continuous Ambulatory Peritoneal Dialysis. eds. Legrain M. - Amsterdam, Excerpta Medica. 1980; 120.
53. Lillevang S., Bangsgaard Pedersen F. The quality of life for hemodialysis patients before and after erythropoetin treatment. A double-blind, randomized placebo-controlled investigation. Ugeskr. Laeger. 1990; 152; 2999.
54. Livesley J. Factors associated with psychiatric symptoms in patients undergoing chronic hemodialysis. Can. J. Psychiatry. 1981; 26; 562.
55. Mayer G., Thum J., Cada E. et al. Aerobic and anaerobic exercise capacity in patients on chronic hemodialysis and long-term recombinant human erytropoetin therapy. Nephron. 1989; 51, Suppl.1. 34.
56. McClellan W., Anson C., Birkeli K., Tuttle E. Functional status and quality of life: predictors of early mortality among patients entering treatment for end stage renal disease. J. Clin. Epidemiol. 1991; 44; 83.
57. McMahon L., Dawborn J. Subjective quality of life assessment in hemodialysis patients at different levels of hemoglobin following use of recombinant human erytropietin. Am. J. Nephrol. 1992; 12; 162.
58. Merkus M.P., Jager K.J., Dekker F.W. et al. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. Am. J. Kidney Dis. 1997; 29; 4: 584-592.
59. Moreno F., Lopez Gomez J.M., Sanz Guajardo D. Quality of life in dialysis patients. A spanish multicentre study. Spanish Cooperative Renal Patients Quality of Life Study Group. Nephrol. Dial. Transplant. 1996; 11; Suppl 2; 125-129.
60. Morris P., Jones B. Life satisfaction across treatment methods for patients with end-stage renal failure. Med. J. Austr. 1989; 150; 428.
61. Morris P., Jones A. Transplantation versus dialysis: a study of quality of life. Transplant. Proc. 1988; 20; 23.
62. Mozes B., Shabtai E., Zucker D. Differences in quality of life among patients receiving dialysis replacement therapy at seven medical centers. J. Clin. Epidemiol. 1997; 50; 9: 1035-43.
63. NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. Am. J. Kidney Dis. 1997; 30; 3: Suppl.2. S67-S138.
64. Nissenson A.R. Cognitive function in dialysis patients: impact of erytrpoetin alfa. New Directions in Anaemia. 1991; 2;1.
65. Nissenson A. Recombinant human erytropoetin: impact on brain and cognitive function, exercise tolerance, sexual potency and quality of life. Semin. Nephrol. 1989; 9; Suppl.2. 25.
66. Parfrey P., Vavasour H., Bullock M. et al. Symptoms in end-stage renal disease: dialysis and transplantation. Transplantation Proc. - 1987; 19; 3407.
67. Parfrey P., Vavasour H., Gault M. A prospective study of health status in dialysis and transplant patients. Transplantation Proc. 1988; 20; 1231.
68. Piehlmeier W., Bullinger M., Kirchberger I. et al. Evaluation of the quality of life of patients with insulin-dependent diabetes mellitus before and after organ transplantation with the SF -36 health survey. Eur. J. Surg. 1996; 162; 12: 933-940.
69. Procci W. Male sexual functioning and maintenance hemodialysis: a prospective study. Dial. Transplant. 1984; 13; 100.
70. Quality of Life Assessment: an Annotated Bibliography. - Geneva. 1994.
71. Reiss D. Patient, family and staff responses to end-stage renal disease. Am. J. Kidney Dis. 1990; 15; 194.
72. USRDS. The 1999 Annual Data Report (ADR): http://www.med.umich.edu/usrds/chapters/adr.html.
73. Sayag R., Kaplan De-Nour A., Shapira Z. et al. Comparison of psychosocial adjustment of male non diabetic kidney transplant and hospital hemodialysis patients. Nephron. 1990; 54; 214.
74. Schlebusch L., Botha G., Bosch B. Coping styles in hemodialysis and continuous peritoneal dialysis patients. Dial. Transplant. 1984; 13; 517.
75. Sensky T. Psyhosomatic aspects of end-stage renal failure. Psynhother. Psychosom. 1993; 59; 56.
76. Simmons R., Anderson C., Abress L. Quality of life and rehabilitation differences among four end-stage renal disease therapy groups. Scand. J. Urol. Nephrol. 1190; 24; Suppl.131. 7.
77. Soskolne V., Kaplan De Nour A. The psychosocial adjusment of patients and spouses to dialisis treatment. Soc. Sci. Med. 1989; 29; 497.
78. Stalmeier V., Kaplan De Nour A. The psychosocial adjusment of parients and spouses to dialisis treatment. Soc. Sci. Med. 1989; 29; 497.
79. Stout J., Auer J., Kincey J. et al. Sexual and marital relationships and dialysis - the patients’s viewpoint. Perit. Dial. Bull. 1987; 7; 97.
80. Theorell T., Konarski-Svensson J., Ahlmen J., Perski A. The role of paid work in Swedish chronic dialysis patients nation - wide survey: paid work and dialysis. J. Int. Med. 1991; 230; 501.
81. Tucker С., Ziller R., Smith W. et al. Quality of life of patients on in-center hemodialysis versus continuous ambulatory peritoneal dialysis. Perit. Dial. Int. 1991; 11; 341.
82. Turner M, Ongkingco R, Hersch S. et al. Effect of r-erythropoietin (Epo) on cognitive function of children with chronic failure. (Abstract). J. Am. Soc. Nephrol. 1991; 2; 390.
83. Tzamaloukas A., Murphy G., Spalding T. Diabetic nephropathy eleven-year survival on hemodialysis. Clin. Nephrol. 1992; 38; 234.
84. Valderrabano F., Moreno F., Arucil F.J. et al. A controlled study of the effect of erythropoietin on the quality of life of elderly hemodialysis patients.(Abstract). J. Am. Soc. Nephrol. 1992; 3; 432.
85. Wadhwa N., Friend R., Russo N. et al. Erytropoietin and quality of life in ESRD patients. (Abstract). J. Am. Soc. Nephrol. 1991; 2; 390.
86. Wai L., Burton H., Richmond J., Lindsay R. Influence of psychosocial factors on survival of home-dialysis patients. Lancet 1981; 2: 8256, 1155-6.
87. Ware J., Snow K., Kosinski M., Gander B. SF-36. Health survey manual and interpretation guide. Boston. 1993.
88. Westlie L., Umen A., Nestrud S., Kjellstrand C. Mortality morbidity an life satisfaction in the very old dialysis patients. Trans. Am. Soc. Artif. Intern. Organs. 1984; 30; 21.
89. Winearls С., Oliver D., Pippard M. et al. Effects of human erytropoietin derived from recombinant DNA on the anemia of patients maintained by chronic hemodialysis. Lancet 1986; 2:8517, 1175-8.
90. Wolcott D., Marsch J., La Rue A. Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. Am. J. Kidney Dis. 1989; 14; 478.
91. Wolcott D., Nissenson A., Landswerk J. Quality of life in chronic dialysis patients. Factors unrelated to dialysis modality. General Hospital Psychiatry. 1988: 10; 2647.
92. Wolcott D., Nissenson A. Quality of life in chronic dialysis patients: a critical comparison of continuous ambulatory peritoneal dialysis and hemodialysis. Am. J. Kidney Dis. 1988; 9; 402.
93. Wolcott D., Schweitzer S., Marsh J. Recombinant erythropoietin improves cognitive function and quality of life (QL) of chronic hemodialysis patients. (Abstract). Kidney Int. 1988; 33: 242.
94. Wuerth D.B., Finkelstein S.H., Juergensen D.M. et al. Quality of life assessment in chronic peritoneal dialysis patients. Adv. Perit. Dial. 1997; 13; 125-7.

Другие статьи по теме

• Качество жизни у больных с терминальной уремией на лечении гемодиализом и перитонеальным диализом
• Фармакотерапия тревожных состояний «Афобазолом» в комплексном лечении больных с хронической почечной недостаточностью
• Состояние системы эритрона у больных с хронической почечной недостаточностью
• Белково-энергетическая недостаточность у больных с терминальной стадией хронической почечной недостаточности, корригируемой различными видами заместительной терапии